DJIA 17,608.77 -63.83 -0.36%
NASDAQ 4,744.54 -13.34 -0.28%
S&P 500 2,041.84 -9.98 -0.49%
market minute promo

MannKind Corp (NASDAQ: MNKD)

company name or ticker

No More Needle Pricks? Potentially Game-Changing News for People With Diabetes

Finger pricks are a common method used by diabetics to check their blood sugar levels. But what if that was about to be a thing of the past?

MannKind Corporation on Track for Afrezza Launch

MannKind partner Sanofi is close to launching its inhaled insulin Afrezza, but will doctors prescribe it?

The Real News About Afrezza From The JPMorgan Conference

In Case You Missed it, Diabetics May Have a New Worry From an Unlikely Source

A new research study suggests that diabetes patients may have more to worry about than just their disease.

Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More

10 Biotech Stories You Might've Missed This Week

Less Mann in MannKind Corporation

Alfred Mann retires as CEO, but investors needn't worry.

Watch MannKind Closely, A Short Squeeze Could Be Nearing

Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger

Griffin Securities Analyst Thinks New MannKind Management Will Focus On R&D, Not Sanofi Merger

See More Articles...